Category: Blog Post
Cholangiocarcinoma Foundation Hails Milestone in Effort to Advance new Treatment for IDH1-positive Cholangiocarcinoma Patients as Agios Announces New FDA Filing for TIBSOVO®
On behalf of patients and families impacted by cholangiocarcinoma (CCA), the Cholangiocarcinoma Foundation (CCF) today hailed progress in the development…
Five for Friday – 5 ways you can join Annual Conference fun
Home / Blog / [wpbb post:title] CCF's 8th Annual Conference is 5 weeks away. The conference will be held virtually…
Cholangiocarcinoma Foundation partners with Japan Cholangiocarcinoma Association to Increase Global Advocacy for Bile Duct Cancer
Cholangiocarcinoma Foundation (CCF), the largest cholangiocarcinoma advocacy organization in the world, has partnered with the newly formed Japan Cholangiocarcinoma Association…
Five for Friday – 5 patient-friendly videos
Home / Blog / [wpbb post:title] Having a cancer diagnosis and trying to figure out treatment options can be very…
‘I Can’t Believe Your Gone’: The Story Behind the Song
Home / Blog Post / 'I Can't Believe Your Gone': The Story Behind the Song Josh Bloomfield was a top…
Five for Friday – 5 ways that you can participate in World Cholangiocarcinoma Day
Home / Blog / [wpbb post:title] Today is World Cholangiocarcinoma Day! World Cholangiocarcinoma (CCA) Day is an international effort to raise…
Five for Friday – 5 ways you can get involved in Awareness Month
Home / Blog / [wpbb post:title] During the month of February, we invite everyone to participate in Awareness Month, with…
Music Video/Lip Sync for the 2021 Annual Conference
The 2021 Cholangiocarcinoma Foundation Virtual Conference is only a few short weeks away. CCF plans to have some fun during…
Five for Friday – 5 clinical trials presented at GI ASCO
Home / Blog / [wpbb post:title] The American Society of Clinical Oncology Gastrointestinal Cancers Symposium (GI ASCO) recognizes the important…
Cholangiocarcinoma Foundation Celebrates 15th Anniversary Milestone
FDA Approves Incyte's Pemazyre™ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma…
Five for Friday – 5 takeaways from GI ASCO
Home / Blog / [wpbb post:title] The American Society of Clinical Oncology Gastrointestinal Cancers Symposium (GI ASCO) is an annual…
Cholangiocarcinoma Foundation Launches Trusted Partners Program
FDA Approves Incyte's Pemazyre™ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma…